$Phase II Study of Yttrium-90-Ibritumomab Tiuxetan in Patients With Relapsed or Refractory Mantle Cell Lymphoma$

Phase II Study of Yttrium-90-Ibritumomab Tiuxetan in Patients With Relapsed or Refractory Mantle Cell Lymphoma

Wang, M.; Oki, Y.; Pro, B.; Romaguera, J. E.; Rodriguez, M. A.; Samaniego, F.; McLaughlin, P.; Hagemeister, F.; Neelapu, S.; Copeland, A.; Samuels, B. I.; Loyer, E. M.; Ji, Y.; Younes, A.

期刊名称Journal of Clinical Oncology
作者Wang, M.; Oki, Y.; Pro, B.; Romaguera, J. E.; Rodriguez, M. A.; Samaniego, F.; McLaughlin, P.; Hagemeister, F.; Neelapu, S.; Copeland, A.; Samuels, B. I.; Loyer, E. M.; Ji, Y.; Younes, A.
卷第27卷
期第31期
印刷ISSN0732-183X
电子ISSN1527-7755
文件大小142.37KB
发表时间2009-11-01
DOI10.1200/JCO.2009.21.8545
页码5213-5218

发现好书期刊，享受阅读乐趣

Phase II Study of Yttrium-90-Ibritumomab Tiuxetan in Patients With Relapsed or Refractory Mantle Cell Lymphoma